|

Tumor Associated Lymph node T cell Clinical Trials

2 actively recruiting trials

Also known as: TAL-T, TAL-T cells

Pipeline

Phase 1: 2

Top Sponsors

  • Guangzhou FineImmune Biotechnology Co., LTD.2

Indications

  • Tumor Associated Lymph Node T Cell2
  • Immunotherapy2
  • Advanced Solid Tumor2
  • Cancer2
  • Serplulimab Injection1

Other2 trials

A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors
Phase 1
Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.